바이오인

2012 The SYBHEL Project

Final Report & Policy Recommendations

Synthetic Biology & Human Health : The Ethical and Legal Issues

Executive Summary

This is the final report of the SYBHEL Project and constitutes deliverable nineteen (D19) as per the SYBHEL Project’s Deion of Work.

The SYBHEL Project consisted of four partners; The University of Zurich, The University of Deusto, The Rathenau Institute and was co-ordinated by the Centre for Ethics in Medicine at the University of Bristol. It was funded by the European Commission’s Science and Society Program- as part of the seventh framework. The SYBHEL Project’s objective was to investigate the ethical, legal and policy issues that may be raised by synthetic biology in respect to human health and wellbeing. It was the first study of its kind to focus on this issue.

Synthetic biology (also known as synbio) is an ostensibly new field of science. This emerging field is interdisciplinary. It draws on a range of different disciplines from genetics, engineering and computing to other forms of biotechnology and biochemistry. Synthetic biology seeks to design and build new living systems and redesign existing biological systems at a molecular, cellular, tissue and organism level. According to proponents, synthetic biology may lead to a wide range of new and radical technologies including applications that could have a significant impact on human health. Applications could include such things as devices for tissue repair or regeneration, personalised smart drugs, therapeutic vectors and new mechanisms for drug uptake or drug design.

.....(계속)

☞ 자세한 내용은 첨부파일을 참고하시기 바랍니다.